
Join to View Full Profile
Department of Radiation Oncology986861 Nebraska Medical CenterOmaha, NE 68198
Phone+1 402-552-3844
Fax+1 402-552-3013
Dr. Enke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
 - Connect with colleagues in the same hospital or clinic.
 - Read the latest clinical news, personalized to your specialty.
 
Summary
- Dr. Charles Enke is a Radiation Oncologist based in Omaha, NE. He completed his residency in radiation oncology at the Medical College of Wisconsin Affiliated Hospitals after earning his medical degree from the University of Iowa Roy J. and Lucille A. Carver College of Medicine in 1985. Since 2008, he has been a professor at Nebraska Medicine - Nebraska Medical Center. Dr. Enke is experienced in stereotactic radiosurgery and has contributed to several publications in his field, covering topics like prostate adenocarcinoma risk stratification and the impact of certain medications on radiation therapy. He received the CMS Meaningful Use Stage 1 Certification in 2013.
 
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Radiation Oncology, 1985 - 1989
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1985
Certifications & Licensure
IA State Medical License 1993 - 2027
NE State Medical License 1989 - 2026
WI State Medical License 1986 - 1991
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
 
Publications & Presentations
PubMed
- PR55α subunit of protein phosphatase 2A supports KRAS-driven tumorigenesis that requires YAP activation.Christopher B Jenkins, Alison L Camero, Brendan T Graff, Lepakshe S V Madduri, Kelly A O'Connell
Oncogene. 2025-09-01 - Predictive Value of Multiparametric Magnetic Resonance Imaging in Risk Group Stratification of Prostate Adenocarcinoma.Benjamin T Bonebrake, Elsa Parr, Linda My Huynh, Brendan Coutu, Neil Hansen
Advances in Radiation Oncology. 2024-06-01 - Exploring the Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Genitourinary Toxicities in Prostate Cancer Patients Undergoing Radiation Therapy: A Case Study an...Kelly Andrianu, Duncan Works, Andrew Christiansen, Charles Enke, Lisa Chaiken
Practical Radiation Oncology. 2024-05-16 
Press Mentions
Nebraska Medicine to Pioneer Breakthrough Proton Therapy Treatment at Fred & Pamela Buffett Cancer CenterMarch 27th, 2025
Cancer Treatment AdvancesJune 29th, 2023
‘Health Care Works Are Exhausted,’ UNMC Letter Receives 2k+ SignaturesNovember 18th, 2020- Join now to see all
 
Professional Memberships
- Member
 
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









